Abstract
BackgroundImmune Checkpoint Inhibitors (ICIs) are associated with long-term survival in ~20% of advanced NSCLC patients while biological mechanisms triggering resistance are not fully elucidated. Myeloid-Derived Suppressor Cells (MDSC) might however...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have